1 – 10 of 358
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Clinical use of polygenic scores in type 2 diabetes: challenges and possibilities
2025) In Diabetologia(
- Contribution to journal › Scientific review
-
Mark
Parent-of-origin effects in the life-course evolution of cardiometabolic traits
2025) In Diabetologia(
- Contribution to journal › Article
-
Mark
Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter]
2025) In Diabetologia(
- Contribution to journal › Letter
- 2024
-
Mark
Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers
(
- Contribution to journal › Article
-
Mark
Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data
(
- Contribution to journal › Article
-
Mark
Caesarean section and risk of type 1 diabetes
(
- Contribution to journal › Article
-
Mark
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes
(
- Contribution to journal › Article
- 2023
-
Mark
Investigating the causal relationships between excess adiposity and cardiometabolic health in men and women
(
- Contribution to journal › Article
-
Mark
Engineered allele substitution at PPARGC1A rs8192678 alters human white adipocyte differentiation, lipogenesis, and PGC-1α content and turnover
(
- Contribution to journal › Article
- 2022
-
Mark
Ex vivo and in vivo experimental investigation of miR-148a-3p as a novel therapy for insulin secretion and type 2 diabetes
2022) EASD, European Association for the Study of Diabetes, 58th annual meeting, In Diabetologia 65(Suppl 1).(
- Contribution to journal › Published meeting abstract